IL SB1773

Amends Illinois Insurance Code Section 356z.59 to expand continuous glucose monitor coverage requirements for group and individual health insurance policies and managed care plans amended, delivered, issued, or renewed on or after January 1, 2024.

Extends coverage for medically necessary continuous glucose monitors to individuals with type 1 or type 2 diabetes, gestational diabetes, maturity-onset diabetes of the young, neonatal diabetes, Wolfram syndrome-caused diabetes, Alstrom syndrome-caused diabetes, latent autoimmune diabetes in adults, steroid-induced diabetes, or cystic fibrosis diabetes.

Limits coverage to individuals who require insulin for the management of their diabetes.

Takes effect January 1, 2024.